A Baltimore biotechnology company is raising up to $40.5 million and working to develop pharmaceutical technology born out of Johns Hopkins University.
The team at Roche’s Basel-based underdog R&D group pRED has something to cheer about today. The FDA has designated their autism drug RG7314 (balovaptan) as a “breakthrough” therapy worthy of VIP treatment at the agency.
Summer RISE is your chance to impact the future workforce of Montgomery County for three weeks in July. Be the organization that gives real career experiences to County youth and helps them realize the opportunities ahead of them.
Nearly all states added jobs in 2017, but the latest Labor Department data suggests most states experienced slower growth last year than in 2016.
Still, it proved to be a particularly strong year for a select group of states — 10 of which recorded year-over-year job gains exceeding 2 percent.
Tanisha Carino, Ph.D., the respected senior executive with more than two decades of experience in academia, government, and the private sector, is joining the Milken Institute as executive director of FasterCures, the center devoted to saving lives and improving the medical research system.
The new year is off to a great start for the partnership between University of Maryland (UMD) and Shanghai’s East China University of Science and Technology (ECUST). This partnership began five years ago when Prof. Greg Payne, from UMD’s Institute for Bioscience and Biotechnology Research (IBBR) and Fischell Department of Bioengineering, was appointed a Chaired Professor in ECUST. The goal of this partnership has been to integrate UMD’s expertise in biofabrication with ECUST’s translational research in biomedical materials. Prof. Changsheng Liu, ECUST’s Vice President and a member of the Chinese National Academy of Sciences, initiated this collaboration as part of ECUST’s efforts to attract international participation in their research programs. “Our work with Maryland has been one of our most successful examples of international collaboration and has led to numerous technical advances while enhancing our graduate student training,” noted Liu.
American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its HIV Functional Cure automated cell processing protocol. This completes a key milestone of AGT’s planned Phase I clinical trial of AGT103-T, a genetically modified autologous T cell product in development as an HIV functional cure.
Join BioBuzz and sponsor BioIT Solutions in Rockville at Bar Louie on February 13th, 2018 from 5 – 7pm. Only a 5 minute walk from the Rockville Metro, please join us for this exciting event. BioIT Solutions offers a range of services from enterprise systems built on their 1Platform4® Suite for advanced computational, workflow, and data management systems to IT strategy, architecture and management consulting. The 1Platform4® Suite consists of a software foundation on which various highly configurable modules are assembled and tailored to each client’s specifications and needs.
Northrop Grumman will form a new business sector focused on new, innovative technology once it closes on its acquisition of Orbital ATK this year, a top Northrop executive said during a Thursday earnings call.
Innovators Magazine asked some biotech stakeholders what trends they expect to see in their markets this year.
The opinions were published in our special biotechnology edition, which was distributed to delegates at an industry conference in Glasgow this week.